GSK J1 ( GSKJ1; GSKJ 1; GSKJ-1 )

Catalog No. M17982 CAS No. 1373422-53-7

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Group Booking Get Quotation Bulk Inquiry Add to Cart

Product Name

GSK J1
Note

Research use only, not for human use.
Brief Description

GSK-J1 is a highly potent H3K27 histone demethylase inhibitor with IC50 of 28 nM and 53 nM in cell-free assays for JMJD3 (KDM6B) and UTX (KDM6A), respectively.
Description

GSKJ1 is a selective and potent histone demethylase inhibitor (GSK-J1) that has significant activity (IC50 60 nM for human JmjD3) in vitro and in cells using an ester derivative (GSK-J4: 1 μM < IC50 < 10 μM; e.g. 9 μM in primary human macrophages). The pyridine regio-isomer GSK-J2 displays significantly less on-target activity (IC50 > 100 μM for human JmjD3) and thus can be used as control for target effects in vitro, and as ester derivative (GSK-J5) in cells. Recent data has shown that GSK-J1 also shows some activity (IC50 950 nM for Jarid1b, IC50 1.76 uM for Jarid1c) against H3K4me3/2/1 demethylases.
Synonyms

GSKJ1; GSKJ 1; GSKJ-1
Pathway

Others
Target

Other Targets
Recptor

JMJD3 (KDM6B);UTX (KDM6A)
Research Area

Others-Field
Indication

——

CAS Number

1373422-53-7
Formula Weight

389.45
Molecular Formula

C22H23N5O2
Purity

98%
Solubility

DMSO : ≥ 33 mg/mL; 84.73 mM
SMILES

OC(=O)CCNC1=CC(=NC(=N1)C1=CC=CC=N1)N1CCC2=C(CC1)C=CC=C2
Chemical Name

3-((2-(pyridin-2-yl)-6-(1,2,4,5-tetrahydro-3H-benzo[d]azepin-3-yl)pyrimidin-4-yl)amino)propanoic acid